Advanced Search Search for:

Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.

Patient / Caregivers / Public

Researchers / Professionals

AACR Foundation

AACR's Impact

About Cancer

Get Involved

Innovators in Discovery

Patient Advocacy

Progress Against Cancer

Survivor Journeys

Ways to Give

AACR Blog

AACR Fellows

AACR History

AACR Newsroom

Stories of the AACR

Awards and Lectureships

Education and Training

In Memoriam

Leadership / Governance

Meetings

Membership

Policy / Govt Affairs

Research

Research Funding

Clear Filters

myAACR

Search for:

Donate Today

Skip to Content

Search for:

myAACR

Cancer Researchers / Other Health Care ProfessionalsCancer Researchers / Other Health Care Professionals
Patients, Caregivers,
and AdvocatesPatients, Caregivers,
and Advocates
Get InvolvedGet Involved
Ways to GiveWays to Give
About the AACRAbout the AACR

Cancer Researchers / Other Health Care Professionals
Patients, Caregivers,
and Advocates
Get Involved
Ways to Give
About the AACR

Home Patients, Caregivers, and Advocates Research New Treatment Approved for Lung Cancer

New Treatment Approved for Lung Cancer

KRAS mutations were once thought to be resistant to drug therapy.

615 Chestnut St., 17th Floor
Philadelphia, PA 19106-4404 USA
Telephone: 215-440-9300
Email: [email protected]

Our Sites

AACR Journals
myAACR
AACR Foundation
AACR Cancer Progress Reports
AACR Blog: Cancer Research Catalyst
Cancer Today Magazine
Leading Discoveries Magazine
CancerCareers.org
AACR Annual Meeting News
AACR Shop

F
T
L
I
Y
S
B

Privacy Policy
Copyright Notice

The American Association for Cancer Research (AACR) is a 501(c)(3) registered nonprofit organization (23-6251648).

Also of Interest:

Healthcare Professionals Membership
What Is Cancer Research
Various Types of Cancer

This website uses cookies to ensure the best user experience. Learn More